{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:46:26Z","timestamp":1776105986662,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00228-015-1867-2","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T13:26:08Z","timestamp":1432560368000},"page":"883-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Are consumers ready to take part in the Pharmacovigilance System?\u2014a Portuguese preliminary study concerning ADR reporting"],"prefix":"10.1007","volume":"71","author":[{"given":"Cristiano","family":"Matos","sequence":"first","affiliation":[]},{"given":"Florence","family":"van Hunsel","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Joaquim","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"issue":"4","key":"1867_CR1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002018-200629040-00004","volume":"29","author":"MT Herdeiro","year":"2006","unstructured":"Herdeiro MT, Figueiras A, Pol\u00f3nia J, Gestal-Otero J (2006) Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting. Drug Saf 29(4):331\u2013340","journal-title":"Drug Saf"},{"issue":"2","key":"1867_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40264-012-0014-6","volume":"36","author":"SN Pal","year":"2013","unstructured":"Pal SN, Duncombe C, Falzon D, Olsson S (2013) WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf 36(2):75\u201381","journal-title":"Drug Saf"},{"key":"1867_CR3","unstructured":"EC. Directive 2010\/84\/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance. Directive 2001\/83\/EC on the Community code relating to medicinal products for human us [online]. Available from URL: http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.douri=OJ:L:2010:348:0074:0099:EN:PDF [Accessed 2011 May 30], 2010."},{"issue":"11","key":"1867_CR4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2165\/11316680-000000000-00000","volume":"32","author":"L Aagaard","year":"2009","unstructured":"Aagaard L, Nielsen LH, Hansen EH (2009) Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 32(11):1067\u20131074","journal-title":"Drug Saf"},{"key":"1867_CR5","volume-title":"The contribution of direct patient reporting to pharmacovigilance","author":"FPAM Hunsel van","year":"2011","unstructured":"van Hunsel FPAM (2011) The contribution of direct patient reporting to pharmacovigilance"},{"key":"1867_CR6","volume-title":"Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys: Prepress Projects Limited","author":"AJ Avery","year":"2011","unstructured":"Avery AJ, Anderson C, Bond C, Fortnum H, Gifford A, Hannaford P, et al. (2011) Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys: Prepress Projects Limited"},{"issue":"2","key":"1867_CR7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2125.2006.02746.x","volume":"63","author":"A Blenkinsopp","year":"2006","unstructured":"Blenkinsopp A, Wilkie P, Wang M, Routledge P (2006) Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 63(2):148\u2013156","journal-title":"Br J Clin Pharmacol"},{"key":"1867_CR8","doi-asserted-by":"crossref","unstructured":"Hazell L, Cornelius V, Hannaford P, Shakir S, Avery AJ (2013) How do patients contribute to signal detection? Drug Saf 1-8","DOI":"10.1007\/s40264-013-0021-2"},{"key":"1867_CR9","doi-asserted-by":"crossref","unstructured":"van Hunsel F, Talsma A, van Puijenbroek E, de Jong-van den Berg L, van Grootheest K. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case\u2013control study. Pharmacoepidemiol Drug Saf. 2011;20(3):286-291.","DOI":"10.1002\/pds.2092"},{"key":"1867_CR10","doi-asserted-by":"crossref","unstructured":"Marques J, Ribeiro-Vaz I, Pereira AC, Pol\u00f3nia J (2013) A survey of spontaneous reporting of adverse drug reactions in 10\u00a0years of activity in a pharmacovigilance centre in Portugal. Int J Pharm Pract","DOI":"10.1111\/ijpp.12078"},{"issue":"5","key":"1867_CR11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2125.2011.03990.x","volume":"72","author":"C Anderson","year":"2011","unstructured":"Anderson C, Krska J, Murphy E, Avery A (2011) The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol 72(5):806\u2013822","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1867_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2710.2011.01273.x","volume":"37","author":"H Fortnum","year":"2012","unstructured":"Fortnum H, Lee A, Rupnik B, Avery A (2012) Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain. J Clin Pharm Ther 37(2):161\u2013165","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"1867_CR13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/pds.2117","volume":"20","author":"DJ McLernon","year":"2011","unstructured":"McLernon DJ, Bond CM, Lee AJ, Watson MC, Hannaford PC, Fortnum H, et al. (2011) Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf 20(5):523\u2013531","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"1867_CR14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00228-010-0865-7","volume":"66","author":"F Hunsel van","year":"2010","unstructured":"van Hunsel F, van der Welle C, Passier A, van Puijenbroek E, van Grootheest K (2010) Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol 66(11):1143\u20131150","journal-title":"Eur J Clin Pharmacol"},{"key":"1867_CR15","volume-title":"Statistical power analysis for the behavioral sciences","author":"J. Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences"},{"issue":"5","key":"1867_CR16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2125.1996.tb00040.x","volume":"41","author":"W. Inman","year":"1996","unstructured":"Inman W (1996) Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol 41(5):434","journal-title":"Br J Clin Pharmacol"},{"key":"1867_CR17","unstructured":"INFARMED. Relat\u00f3rio anual 2013 - Notifica\u00e7\u00f5es e Casos de RAM recebidos no SNF (Sistema Nacional de Farmacovigil\u00e2ncia). 2014."},{"key":"1867_CR18","unstructured":"INFARMED. Relat\u00f3rio anual 2012 - Notifica\u00e7\u00f5es e Casos de RAM recebidos no SNF (Sistema Nacional de Farmacovigil\u00e2ncia). 2013."},{"issue":"1","key":"1867_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00228-008-0564-9","volume":"65","author":"E Ekman","year":"2009","unstructured":"Ekman E, B\u00e4ckstr\u00f6m M (2009) Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol 65(1):43\u201346","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"1867_CR20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0895-4356(02)00450-X","volume":"55","author":"J Hasford","year":"2002","unstructured":"Hasford J, Goettler M, Munter K-H, M\u00fcller-Oerlinghausen B (2002) Physicians\u2019 knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 55(9):945\u2013950","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1867_CR21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002280050314","volume":"52","author":"K. Belton","year":"1997","unstructured":"Belton K (1997) Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 52(6):423\u2013427","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"1867_CR22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00002018-200528090-00007","volume":"28","author":"MT Herdeiro","year":"2005","unstructured":"Herdeiro MT, Figueiras A, Pol\u00f3nia J, Gestal-Otero JJ (2005) Physicians\u2019 attitudes and adverse drug reaction reporting. Drug Saf 28(9):825\u2013833","journal-title":"Drug Saf"},{"issue":"8","key":"1867_CR23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF03261962","volume":"35","author":"MT Herdeiro","year":"2012","unstructured":"Herdeiro MT, Ribeiro-Vaz I, Ferreira M, Pol\u00f3nia J, Falc\u00e3o A, Figueiras A (2012) Workshop- and telephone-based interventions to improve adverse drug reaction reporting. Drug Saf 35(8):655\u2013665","journal-title":"Drug Saf"},{"issue":"1","key":"1867_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez E, Herdeiro MT, Figueiras A (2009) Determinants of under-reporting of adverse drug reactions. Drug Saf 32(1):19\u201331","journal-title":"Drug Saf"},{"issue":"1","key":"1867_CR25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0034-89102010005000050","volume":"45","author":"I Ribeiro-Vaz","year":"2011","unstructured":"Ribeiro-Vaz I, Herdeiro MT, Pol\u00f3nia J, Figueiras A (2011) Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica 45(1):129\u2013135","journal-title":"Rev Saude Publica"},{"key":"1867_CR26","volume-title":"Improving pharmacovigilance and the role of the pharmacist: Centre Lareb","author":"AC Grootheest Van","year":"2003","unstructured":"Van Grootheest AC (2003) Improving pharmacovigilance and the role of the pharmacist: Centre Lareb"},{"issue":"9-10","key":"1867_CR27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s002280000202","volume":"56","author":"M B\u00e4ckstr\u00f6m","year":"2000","unstructured":"B\u00e4ckstr\u00f6m M, Mj\u00f6rndal T, Dahlqvist R, Nordkvist-Olsson T (2000) Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol 56(9-10):729\u2013732","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1867_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1099-1557(199701)6:1<21::AID-PDS259>3.0.CO;2-I","volume":"6","author":"C Biriell","year":"1997","unstructured":"Biriell C, Edwards IR (1997) Reasons for reporting adverse drug reactions\u2014some thoughts based on an international review. Pharmacoepidemiol Drug Saf 6(1):21\u201326","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"1867_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00002018-200730080-00003","volume":"30","author":"BA Golomb","year":"2007","unstructured":"Golomb BA, McGraw JJ, Evans MA, Dimsdale JE (2007) Physician response to patient reports of adverse drug effects. Drug Saf 30(8):669\u2013675","journal-title":"Drug Saf"},{"issue":"7465","key":"1867_CR30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bmj.329.7465.573","volume":"329","author":"C. Frankenfeld","year":"2004","unstructured":"Frankenfeld C (2004) \u201cSerious\u201d and \u201csevere\u201d adverse drug reactions need defining. BMJ 329(7465):573","journal-title":"BMJ"},{"key":"1867_CR31","doi-asserted-by":"crossref","unstructured":"Rolfes L, Hunsel F, Wilkes S, Grootheest Kv, Puijenbroek Ev. Adverse drug reaction reports of patients and healthcare professionals\u2014differences in reported information. Pharmacoepidemiol Drug Saf. 2014.","DOI":"10.1002\/pds.3687"},{"key":"1867_CR32","doi-asserted-by":"crossref","unstructured":"Cohen J (2013) Statistical power analysis for the behavioral sciences. Routledge Academic","DOI":"10.4324\/9780203771587"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1867-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1867-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T03:36:03Z","timestamp":1652067363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1867-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1867"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1867-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}